ESS
79
2
MOS
19
3
FITB
48
3
OMC
53
3
MPC
44
2
NFLX
69
4
NUE
37
-2
PEP
38
2
PX
46
4
RIG
28
2
SO
68
2
AAL
30
-2
PVH
59
-3
APD
57
2
UNH
34
-2
PDCO
65
19
GLW
64
3
FIS
55
5
MS
61
2
PBI
23
-3
ESS
79
2
MOS
19
3
FITB
48
3
OMC
53
3
MPC
44
2
NFLX
69
4
NUE
37
-2
PEP
38
2
PX
46
4
RIG
28
2
SO
68
2
AAL
30
-2
PVH
59
-3
APD
57
2
UNH
34
-2
PDCO
65
19
GLW
64
3
FIS
55
5
MS
61
2
PBI
23
-3
Financhill
Back

AbCellera Biologics Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
33

ABCL
AbCellera Biologics

Last Price:
3.02
Seasonality Move:
-13.16%
Sell
35

RARE
Ultragenyx Pharmaceutical

Last Price:
37.44
Seasonality Move:
3.65%
Sell
33
AbCellera Biologics (ABCL) is a Sell

Is AbCellera Biologics a Buy, Sell or Hold?

  • The current AbCellera Biologics [ABCL] share price is $3.02. The Score for ABCL is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • ABCL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
35
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $37.42. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABCL Stock Price Chart

What is AbCellera Biologics's stock price today?

  • The AbCellera Biologics share price today is $3.02
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABCL is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $37.42
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

ABCL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.21 Sell
Relative Strength Index (14 RSI): 21.78 Sell
Chaikin Money Flow: -1235950 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.39 - 3.97) Sell
Bollinger Bands (100): (3.75 - 4.97) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.58 Sell
Relative Strength Index (14 RSI): 37.74 Sell
Chaikin Money Flow: -836354 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.26 - 42.36) Sell
Bollinger Bands (100): (41.26 - 48.86) Sell

ABCL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.33 Sell
20-day SMA: 3.67 Sell
50-day SMA: 3.84 Sell
200-day SMA: 4.62 Sell
8-day EMA: 3.3 Sell
20-day EMA: 3.55 Sell
50-day EMA: 3.86 Sell
200-day EMA: 4.87 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.11 Sell
20-day SMA: 40.61 Sell
50-day SMA: 42.43 Sell
200-day SMA: 42.45 Sell
8-day EMA: 40.32 Sell
20-day EMA: 40.92 Sell
50-day EMA: 42.29 Sell
200-day EMA: 43.55 Sell

AbCellera Biologics Earnings Growth & ABCL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.03 per share, a decrease this year of $0.10 per share, and a decrease next year of $0.06 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

AbCellera Biologics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):